| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Calidi Biotherapeutics, Inc. | Interim Chief Medical Officer | Common Stock | 424,458 | $764,024 | $1.80 | 12 Sep 2023 | Direct |
| Calidi Biotherapeutics, Inc. | Interim Chief Medical Officer | Stock Options (right to buy) | 31,360 | 17 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics, Inc. | 17 Jun 2024 | 1 | $0 | 4 | Interim Chief Medical Officer | 20 Jun 2024, 20:56 |
| CLDI | Calidi Biotherapeutics, Inc. | 12 Sep 2023 | 0 | $0 | 3 | Interim Chief Medical Officer | 25 Sep 2023, 18:39 |